NEW YORK (GenomeWeb) – Nanosphere reported today that its fourth quarter revenues grew nearly 48 percent year over year driven by sales of its infectious disease tests.

For the three months ended Dec. 31, 2015, the company reported revenues of $6.8 million compared to $4.6 million in Q4 2014, and in line with its preliminary earnings announcement in January.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.